EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Systematic review of thyroid function in NKX2-1-related disorders: Screening and diagnosis

Beatriz Carmona-Hidalgo iD, Carmen Martín-Gómez, Estefanía Herrera-Ramos, Rocío Rodríguez-López, Laia-Nou Fontanet, José C Moreno, Juan Antonio Blasco-Amaro, Juliane Léger, Juan Dario-Ortigoza-Escobar iD, NKX2-1-Related Disorders Guideline Working Group

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0303880 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS ONE, 2024. Verfasst von Beatriz Carmona-Hidalgo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Health Technology Assessment Area-AETSA, Andalusian Public Foundation for Progress and Health ("Fundación Progreso y Salud"-"FPS"), Seville, Spain. Hauptthemen laut MEDLINE: Congenital Hypothyroidism, Thyroid Nuclear Factor 1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, European Reference Network for Rare Neurological Diseases,.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

NKX2-1 -related disorders ( NKX2-1 -RD) are rare conditions affecting lung, thyroid, and brain development, primarily caused by pathogenic variants or deletions in the NKX2-1 gene. Congenital hypothyroidism (CH) is a common endocrine manifestation, leading to irreversible intellectual disability if left untreated.

Objectives

The aim was to evaluate the current evidence for the use of screening and diagnostic techniques for endocrine alterations in patients with NKX2-1 -RD.

Methods

This systematic review was reported following the PRISMA guidelines. Two separate research questions in PICO format were addressed to cover initial screening and diagnosis procedures for endocrine diseases in patients with NKX2-1 -RD. Eligibility criteria focused on patients with genetic confirmation of the disease and hypothyroidism. Various databases were searched, and data were extracted and assessed independently by two reviewers.

Results

Out of 1012 potentially relevant studies, 46 were included, for a total of 113 patients. CH was the most frequent endocrine alteration (45% of patients). Neonatal screening was reported in only 21% of patients based on blood TSH measurements. TSH thresholds varied widely across studies, making hypothyroidism detection ranges difficult to establish. Diagnostic tests using serum TSH were used to diagnose hypothyroidism or confirm its presence. 35% of patients were diagnosed at neonatal age, and 42% at adult age. Other hormonal dysfunctions identified due to clinical signs, such as anterior pituitary deficiencies, were detected later in life. Thyroid scintigraphy and ultrasonography allowed for the description of the thyroid gland in 30% of cases of hypothyroidism. Phenotypic variability was observed in individuals with the same variants, making genotype-phenotype correlations challenging.

Conclusion

This review highlights the need for standardized protocols in endocrine screening for NKX2-1 -RD, emphasizing the importance of consistent methodology and hormone threshold levels. Variability in NKX2-1 gene variants further complicates diagnostic efforts. Future research should concentrate on optimizing early screening protocols and diagnostic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Congenital HypothyroidismThyroid Nuclear Factor 1HumansInfant, NewbornNeonatal ScreeningThyroid Function TestsThyroid GlandThyrotropin

Substanzen

NKX2-1 protein, humanThyroid Nuclear Factor 1Thyrotropin

Autor:innen und Institutionen

  • Health Technology Assessment Area-AETSA, Andalusian Public Foundation for Progress and Health ("Fundación Progreso y Salud"-"FPS"), Seville, Spain.
  • Research Group HUM604: Lifestyle Development in the Life Cycle and Health Promotion, University of Huelva, Huelva, Spain.
  • Evaluation Unit of the Canary Islands Health Service (SESCS), Canary Islands Health Research Institute Foundation (FIISC), Santa Cruz of Tenerife, Spain.
  • Department of Child Neurology, Movement Disorders Unit, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
  • Thyroid Molecular Laboratory, Institute for Medical and Molecular Genetics (INGEMM). Research Institute of Paz University Hospital (IdiPAZ), Madrid, Spain.
  • U-753 The Rare Diseases Networking Biomedical Research Centre (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.

ORCID-Profile: Beatriz Carmona-Hidalgo, Juan Dario-Ortigoza-Escobar

Förderung

  • European Commission
  • European Reference Network for Rare Neurological Diseases,

Zitieren

APA

Carmona-Hidalgo, B., Martín-Gómez, C., Herrera-Ramos, E., Rodríguez-López, R., Fontanet, L. N., Moreno, J. C., Blasco-Amaro, J. A., Léger, J., Dario-Ortigoza-Escobar, J., & NKX2-1-Related Disorders Guideline Working Group (2024). Systematic review of thyroid function in NKX2-1-related disorders: Screening and diagnosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0303880

Vancouver

Carmona-Hidalgo B, Martín-Gómez C, Herrera-Ramos E, Rodríguez-López R, Fontanet LN, Moreno JC, et al. Systematic review of thyroid function in NKX2-1-related disorders: Screening and diagnosis. PLOS ONE. 2024. doi:10.1371/journal.pone.0303880

BibTeX
@article{CarmonaHidalgo2024,
  author = {Carmona-Hidalgo, Beatriz and Martín-Gómez, Carmen and Herrera-Ramos, Estefanía and Rodríguez-López, Rocío and Fontanet, Laia-Nou and Moreno, José C and Blasco-Amaro, Juan Antonio and Léger, Juliane and Dario-Ortigoza-Escobar, Juan and NKX2-1-Related Disorders Guideline Working Group, NKX2-1-Related Disorders Guideline Working Group},
  title = {Systematic review of thyroid function in NKX2-1-related disorders: Screening and diagnosis},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0303880}
}
Kostenlos starten →